Human studies into phosphorylation of titin in heart disease are generally in agreement with the animal models in that an overall decrease (vs. nonfailing hearts) occurs in all‐titin phosphorylation and site‐specific N2Bus phosphorylation, whereas hyperphosphorylation occurs at PEVK phosphosite S11878 (Fig. 5). Here, TTN is linked to heart disorder.